Laboratory fume hoods and containment enclosures manufacturer
AirClean Systems builds ductless fume hoods, PCR workstations and lab containment enclosures from its Creedmoor, NC plant. Its stack pairs a Microsoft ERP core (Dynamics 365 Finance and Operations, Supply Chain Management, X++, Azure Synapse, Power BI) with factory automation from Allen-Bradley, Fanuc, Cognex and Keyence. Job posts cite FDA 510(k) and EU medical device filings, pointing to a push into regulated medical markets alongside junior-heavy manufacturing hiring.
AirClean Systems is a privately held manufacturer founded in 1992 and headquartered in Creedmoor, North Carolina. It makes equipment that shields laboratory staff and processes from hazardous vapors, fumes, gases and particulates. The product line covers ductless and exhaust fume hoods, PCR workstations, balance enclosures, laminar flow benches and forensic containment systems. The company employs 51–200 people and runs in-house electronic and mechanical design at its own manufacturing facility. It hires in the United States.
AirClean Systems runs Microsoft Dynamics 365 Finance and Operations and Supply Chain Management, customized with X++, with reporting through Power BI, SQL Server Reporting Services and Azure Synapse.
AirClean Systems makes ductless and exhaust fume hoods, PCR workstations, balance enclosures, laminar flow benches and forensic containment products for laboratories.
AirClean Systems is headquartered in Creedmoor, North Carolina, United States, where it also does manufacturing and design. It has 51–200 employees.
Other companies in the same industry, closest in size
AirClean Systems's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.